Compare AU
Compare IISV vs. IXJ
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Intell Investor Select Value Shr Fund - Active ETF (IISV) and the iShares Global Healthcare ETF (IXJ). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
IISV | IXJ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 11 | 241 |
Median incremental investment | $665.13 | $1,000.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $4,559.49 | $1,671.24 |
Average age group | 26 - 35 | 26 - 35 |
Key Summary
IISV | IXJ | |
|---|---|---|
Strategy | IISV.AX was created on 2023-03-31 by Intelligent Investor . The fund's investment portfolio concentrates primarily on total market equity. The portfolio aims to outperform the S&P/ASX 200 Accumulation Index p.a. over five year rolling periods with minimal turnover to allow returns to compound in a favourable tax environment | IXJ.AX was created on 2001-11-13 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of global biotechnology, healthcare, medical equipment and pharmaceuticals companies and may include large-, mid- or smallcapitalisation stocks |
Top 3 holdings | RPMGlobal Holdings Ltd (7.77 %) Fairfax Financial Holdings Ltd Shs Subord.Vtg (6.95 %) KKR & Co Inc Ordinary Shares (5.57 %) | Eli Lilly and Company (8.25 %) UnitedHealth Group Incorporated (5.81 %) Johnson & Johnson (4.72 %) |
Top 3 industries | Financials (50.65 %) Consumer Discretionary (15.93 %) Information Technology (14.85 %) | Other (99.98 %) Communication Services (0.02 %) |
Top 3 countries | United States (42.65 %) Australia (20.03 %) United Kingdom of Great Britain and Northern Ireland (15.60 %) | United States (99.97 %) |
Management fee | 0.97 % | 0.46 % |
Key Summary
IISV | IXJ | |
|---|---|---|
Issuer | Intelligent Investor | iShares |
Tracking index | S&P/ASX 200 Accumulation Index - AUD - Benchmark TR Net | S&P Global 1200 Healthcare Sector Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.97 % | 0.46 % |
Price | $3.54 | $138.91 |
Size | N/A | $1.373 billion |
10Y return | N/A | 123.15 % |
Annual distribution yield (5Y) | 0.07 % | 1.26 % |
Market | ASX | ASX |
First listed date | 30/03/2023 | 11/03/2009 |
Purchase fee | $6.50 | $6.50 |
Community Stats
IISV | IXJ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 11 | 241 |
Median incremental investment | $665.13 | $1,000.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $4,559.49 | $1,671.24 |
Average age group | 26 - 35 | 26 - 35 |
Pros and Cons
IISV | IXJ | |
|---|---|---|
Pros |
|
|
Cons |
|
|
IISV | IXJ |
|---|---|
Higher exposure to AU market | Lower exposure to AU market |
Lower exposure to US market | Higher exposure to US market |
Higher management fee | Lower management fee |
Lower price growth | Higher price growth |
Lower distribution yield | Higher distribution yield |